Blood Donation Research Today is a free monthly online journal that collates and summarizes the latest research about Blood Donation, including details on blood types, blood group, leukemia, red cross.

Recommended Books on Blood Donation

The 2007-2012 Outlook for Medical and Surgical Blood Transfusion and IV Equipment and Blood Donor Kits in Greater China This study covers the latent demand outlook for medical and surgical blood transfusion and IV equipment and blood donor kits across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of “economic population”, as opposed to the demographic population within a legal geographic boundary. For many cities, the economic population is much larger that the population within the city limits; this is especially true for the cities of the Western regions. For the coastal regions, cities which are close to other major cities or which represent, by themselves, a high percent of the regional population, actual city-level population is closer to the economic population (e.g. in Beijing). Based on this “economic” definition of population, comparative benchmarks allow the reader to quickly gauge a city’s marketing and distribution value vis-à-vis others. This exercise is quite useful for persons setting up distribution centers or sales force strategies. Using econometric models which project fundamental economic dynamics within each region and city of influence, latent demand estimates are created for medical and surgical blood transfusion and IV equipment and blood donor kits. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

The 2009-2014 Outlook for Medical and Surgical Blood Transfusion and IV Equipment and Blood Donor Kits in Greater China This econometric study covers the latent demand outlook for medical and surgical blood transfusion and IV equipment and blood donor kits across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as "regions"). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in Greater China. For each major city in question, the percent share the city is of the region and of Greater China is reported. Each major city is defined as an area of "economic population", as opposed to the demographic population within a legal geographic boundary. For many cities, the economic population is much larger that the population within the city limits; this is especially true for the cities of the Western regions. For the coastal regions, cities which are close to other major cities or which represent, by themselves, a high percent of the regional population, actual city-level population is closer to the economic population (e.g. in Beijing). Based on this "economic" definition of population, comparative benchmarks allow the reader to quickly gauge a city's marketing and distribution value vis-a-vis others. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

Blood Donors and the Supply of Blood and Blood Products Selected papers from the Forum on Blood Safety and Blood Availability meetings organized by the Institute of Medicine. Papers presented at a workshop held in Washington D.C. June 8-9, 1995. Softcover. 16 U.S. contributors.

The 2007-2012 World Outlook for Medical and Surgical Blood Transfusion and IV Equipment and Blood Donor Kits This study covers the world outlook for medical and surgical blood transfusion and IV equipment and blood donor kits across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with Hepatitis C [An article from: Social Science & Medicine] This digital document is a journal article from Social Science & Medicine, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
Clinical medicine and biotechnology increasingly utilise and transform human bodily tissues in novel ways. Today more and more tissues-blood, whole organs, ova, embryos, sperm, skin, bone, heart valves, cellular material, bone marrow and corneas-can be transferred between donors and recipients. Hence more and more people in developed nations have the experience of giving a fragment of their body to another, or receiving such a fragment as part of some kind of therapy. These systems for the circulation of tissues raise the question of what we have termed 'bioidentity'. Bioidentity describes our common-sense understanding of our bodies as 'ours', as both supporting and being included in our social and subjective identities. Within this framework, how are we to understand the status of detachable bodily fragments like blood, ova or organs? As parts of our bodies do they retain a trace of our identity after donation, or are they detachable things? What is our relationship, if any, to the patient who receives our tissues as part of their treatment? This paper investigates the specific case of blood transfusion and donation. It draws upon in depth interviews with 55 people who have specific experience with blood. They either have hepatitis C (are HCV+) acquired by transfusion or intravenous drug use, or have donated blood or received a blood transfusion but are free of hepatitis C (are HCV-). We analyse this material according to the themes-Donated Blood as 'Self', Blood as Alienable, Blood as Communal Substance, and Contaminated Gifts and the Blood of Strangers. We find that, generally speaking the HCV+ and HCV- groups share very similar ideas about blood donation and transfusion. For a minority of both groups, blood was understood as a decisive site of self irrespective of location, but for the remainder donated blood was either ambiguous with regard to identity, a shared substance, or not considered to have any lingering relationship to the self once given. However both groups regarded blood as strongly imbued with 'risk identity'. In particular the HCV+ interviewees regarded their blood as a dangerous personal attribute, one that they must be careful to withhold from circulation, whereas the blood donors felt obliged to donate their blood precisely because they considered it clean and risk free.

Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors [An article from: Chemosphere] This digital document is a journal article from Chemosphere, published by Elsevier in 2007. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
The purpose of this pilot study was to determine whether perfluorooctanesulfonate (PFOS,C"8F"1"7SO"3^-) and perfluorooctanoate (PFOA,C"7F"1"5CO"2^-) concentrations in American Red Cross blood donors from Minneapolis-St. Paul, Minnesota have declined after the 2000-2002 phase-out of perfluorooctanesulfonyl-fluoride (POSF, C"8F"1"7SO"2F)-based materials by the primary global manufacturer, 3M Company. Forty donor plasma samples, categorized by age and sex, were collected in 2005, and PFOS and PFOA concentrations were compared to 100 (non-paired) donor serum samples collected in 2000 from the same general population that were analyzed at the time using ion-pair extraction methods with tetrahydroperfluorooctanesulfonate as an internal standard. Eleven of the 100 samples originally collected were reanalyzed with present study methods that involved ^1^3C- labeled PFOA spiked into the donor samples, original samples, control human plasma, and the calibration curve prior to extraction, and was used as a surrogate to monitor extraction efficiency. Quantification was performed by high performance liquid chromatography tandem mass spectrometry methods. Among the 100 serum samples analyzed for PFOS, the geometric mean was 33.1ngml^-^1 (95% CI 29.8-36.7) in 2000 compared to 15.1ngml^-^1 (95% CI 13.3-17.1) in 2005 (p<0.0001) for the 40 donor plasma samples. The geometric mean concentration for PFOA was 4.5ngml^-^1 (95% CI 4.1-5.0) in 2000 compared to 2.2ngml^-^1 (95% CI 1.9-2.6) in 2005 (p<0.0001). The decrease was consistent across donors' age and sex. To confirm these preliminary findings, additional sub-sets of year 2000 samples will be analyzed, and a much larger biomonitoring study of other locations is planned.

Diary of a Blood Donor In this contemporary retelling of Bram Stoker's Dracula, Estonian writer Mati Unt offers a playful yet unsettling mixture of fact and fiction, combining pieces of Estonian political history—in particular the figure of Lydia Koidula (1843-1886), widely regarded as the first Estonian woman to express an Estonian longing for independence—with portraits of life in contemporary Estonia, all set against a backdrop of vampirism and the Gothic novel.

Blood Donor Private investigator, Mina Black, uncovers the horrible truth about the patients at Paradise Regional. Their blood is being contaminated as part of a gruesome experiment done by the Vampire Council to create a new breed that can rise during the day. Mina quickly becomes involved in a fight for survival when they decide to use her in their experiments. They believe her half-vampire blood is the key to dominating the subversive underworld and when she refuses to assist them, the Council becomes bent on getting a sample of Mina's unique blood, no matter what the cost. She has no choice but involve her partner and the local authorities, throwing them all headlong into a dark and terrifying ride full of dangerous twists and turns. Every corner is a possible trap and with time running out for her and the patients, Mina decides she must take a stand against these evil creatures before it's too late. Alliances will change and new enemies will be made as Mina fights to keep the monsters at bay, conceal the secret of her own blood and sort out the tangled shreds of her love life.

The 2009-2014 World Outlook for Medical and Surgical Blood Transfusion and IV Equipment and Blood Donor Kits This econometric study covers the world outlook for medical and surgical blood transfusion and IV equipment and blood donor kits across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for medical and surgical blood transfusion and IV equipment and blood donor kits. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

The 2009 Report on Medical and Surgical Blood Transfusion and IV Equipment and Blood Donor Kits: World Market Segmentation by City This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major city of the world. It then ranks these cities and reports them in terms of their size as a percent of the country where they are located, their geographic region (e.g. Africa, Asia, Europe, Middle East, North America, Latin America), and the total world market.

In performing various economic analyses for its clients, I have been occasionally asked to investigate the market potential for various products and services across cities. The purpose of the studies is to understand the density of demand within a country and the extent to which a city might be used as a point of distribution within its region. From an economic perspective, however, a city does not represent a population within rigid geographical boundaries. To an economist or strategic planner, a city represents an area of dominant influence over markets in adjacent areas. This influence varies from one industry to another, but also from one period of time to another.

In what follows, I summarize the economic potential for the world's major cities for "medical and surgical blood transfusion and IV equipment and blood donor kits" for the year 2009. The goal of this report is to report my findings on the real economic potential, or what an economist calls the latent demand, represented by a city when defined as an area of dominant influence. The reader needs to realize that latent demand may or may not represent real sales.

© 2005-2012 Blood Donation Research Today. All Rights Reserved.